Homocysteine is associated with higher risks of ischemic stroke: A systematic review and meta-analysis
Carregando...
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
NASCIMENTO, Rafaela Farias Vidigal
Citação
PLOS ONE, v.17, n.10, article ID e0276087, 20p, 2022
Resumo
Background High levels of homocysteine (Hct) have been associated with great risks of ischemic stroke. However, some controversy still exists. We performed a systematic review and meta-analysis to compare the levels of Hct between patients with ischemic stroke and controls. Methods We performed a systematic literature search for articles reporting Hct levels of patients with occurrence of ischemic stroke. We employed a random-effects inverse-variance weighted meta-analytical approach in order to pool standardized mean differences, with estimation of tau(2) through the DerSimonian-Laird method. Results The initial search yielded 1361 studies. After careful analysis of abstracts and full texts, the meta-analysis included data from 38 studies, which involved almost 16 000 stroke events. However, only 13 studies reported means and standard deviations for cases and controls, and therefore were used in the meta-analysis. Those studies presented data from 5002 patients with stroke and 4945 controls. Standardized mean difference was 1.67 (95% CI 1.00-2.25, P < 0.01), indicating that Hct levels were significantly larger in patients with ischemic stroke compared to controls. Between-study heterogeneity was very large (I-2 = 99%), particularly because three studies showed significantly large mean differences. Conclusion This meta-analysis shows that patients with ischemic stroke have higher levels of Hct compared to controls. Whether this is a modifiable risk factor remains to be assessed through larger prospective cohorts.
Palavras-chave
Referências
- Acampa M, 2016, J STROKE, V18, P157, DOI 10.5853/jos.2015.01599
- Acampa M, 2011, CLIN TRANSPLANT, V25, P119, DOI 10.1111/j.1399-0012.2009.01126.x
- ARAKI A, 1989, ATHEROSCLEROSIS, V79, P139, DOI 10.1016/0021-9150(89)90118-4
- Ashjazadeh N, 2013, IRAN J MED SCI, V38, P233
- Bayir A, 2010, NEUROL RES, V32, P115, DOI 10.1179/016164109X12445616596201
- Beyan C, 2013, CLIN NEPHROL, V80, P311, DOI 10.5414/CN108055
- Biswas A, 2009, J STROKE CEREBROVASC, V18, P103, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.014
- Bokhari FA, 2012, TRANSL NEUROSCI, V3, P41, DOI 10.2478/s13380-012-0005-1
- Bots ML, 1999, ARCH INTERN MED, V159, P38, DOI 10.1001/archinte.159.1.38
- BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049
- Chambers JC, 2000, LANCET, V355, P523, DOI 10.1016/S0140-6736(99)93019-2
- Chen JJ, 2017, CELL MOL NEUROBIOL, V37, P1399, DOI 10.1007/s10571-017-0470-8
- Cotlarciuc I, 2014, STROKE, V45, P1920, DOI 10.1161/STROKEAHA.114.005208
- Dai DP, 2019, ANN NUTR METAB, V75, P9, DOI 10.1159/000501191
- Dhamija RK, 2009, J NEUROL SCI, V281, P64, DOI 10.1016/j.jns.2009.02.341
- Djuric D, 2018, CAN J PHYSIOL PHARM, V96, P991, DOI 10.1139/cjpp-2018-0112
- Evers S, 1997, ARCH NEUROL-CHICAGO, V54, P1276, DOI 10.1001/archneur.1997.00550220074017
- Fan YL, 2018, J AM SOC HYPERTENS, V12, P534, DOI 10.1016/j.jash.2018.03.011
- Folate, VIT B12 RISK ISCH HE
- Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204
- GENEST JJ, 1990, J AM COLL CARDIOL, V16, P1114, DOI 10.1016/0735-1097(90)90542-W
- Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775
- Gungor L, 2018, J STROKE CEREBROVASC, V27, P1921, DOI 10.1016/j.jstrokecerebrovasdis.2018.02.033
- Haapaniemi E, 2007, EUR J NEUROL, V14, P12, DOI 10.1111/j.1468-1331.2006.01518.x
- Hankey GJ, 2006, NAT CLIN PRACT NEURO, V2, P26, DOI 10.1038/ncpneuro0093
- He YS, 2014, NUTR METAB CARDIOVAS, V24, P1158, DOI 10.1016/j.numecd.2014.05.011
- Hogeveen M, 2002, J PEDIATR-US, V141, P429, DOI 10.1067/mpd.2002.126598
- HOPKINS PN, 1995, ARTERIOSCL THROM VAS, V15, P1314, DOI 10.1161/01.ATV.15.9.1314
- Hultdin J, 2011, CLIN CHEM LAB MED, V49, P1555, DOI 10.1515/CCLM.2011.234
- Iso H, 2004, CIRCULATION, V109, P2766, DOI 10.1161/01.CIR.0000131942.77635.2D
- Ji Y, 2013, NEUROLOGY, V81, P1298, DOI 10.1212/WNL.0b013e3182a823cc
- Joubran R, 1998, J Cardiovasc Risk, V5, P257, DOI 10.1097/00043798-199808000-00008
- Kalita J, 2009, CLIN NEUROL NEUROSUR, V111, P364, DOI 10.1016/j.clineuro.2008.12.010
- Kawamoto R, 2003, INTERNAL MED, V42, P571, DOI 10.2169/internalmedicine.42.571
- Kelly PJ, 2002, NEUROLOGY, V59, P529, DOI 10.1212/WNL.59.4.529
- Kelly PJ, 2004, STROKE, V35, P12, DOI 10.1161/01.STR.0000106481.59944.2F
- Kwon HM, 2014, STROKE, V45, P871, DOI 10.1161/STROKEAHA.113.004099
- Lehotsky J, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00538
- Li Y, 2017, NEUROL SCI, V38, P811, DOI 10.1007/s10072-017-2848-2
- Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D
- LINDGREN A, 1995, STROKE, V26, P795, DOI 10.1161/01.STR.26.5.795
- Ling-Cong, 2018, REV ASSOC MED BRAS, V64, P438, DOI 10.1590/1806-9282.64.05.438
- Lu SS, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1203-4
- Ma YT, 2010, NEUROL RES, V32, P636, DOI 10.1179/016164109X12445616596445
- Macko Richard F, 2002, J Stroke Cerebrovasc Dis, V11, P1, DOI 10.1053/jscd.2002.123968
- Malinow MR., ATHEROSCLEROSIS, V126, P27
- Mansoor M, 1997, HEART, V77, P390, DOI 10.1136/hrt.77.4.390
- Mizrahi EH, 2005, ARCH PHYS MED REHAB, V86, P60, DOI 10.1016/j.apmr.2004.01.031
- Niazi F, 2019, CUREUS, V11, DOI 10.7759/cureus.5625
- Omrani HQ, 2011, ARYA ATHEROSCLER, V7, P97
- Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]
- PANCHARUNITI N, 1994, AM J CLIN NUTR, V59, P940, DOI 10.1093/ajcn/59.4.940
- Peeters AC, 2007, J VASC SURG, V45, P701, DOI 10.1016/j.jvs.2006.12.019
- Peng H, 2000, J Tongji Med Univ, V20, P330
- Perini F, 2005, NEUROL SCI, V26, P310, DOI 10.1007/s10072-005-0505-7
- PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8
- ROBINSON K, 1995, CIRCULATION, V92, P2825, DOI 10.1161/01.CIR.92.10.2825
- Rudreshkumar KJ, 2018, CLIN NUTR, V37, P1715, DOI 10.1016/j.clnu.2017.07.005
- Sawula W, 2009, CLIN BIOCHEM, V42, P442, DOI 10.1016/j.clinbiochem.2008.12.019
- Schwartz SM, 1997, CIRCULATION, V96, P412
- Shademan B, 2021, J CLIN LAB ANAL, DOI 10.1002/jcla.23996
- Shi ZH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25398-5
- Shi ZH, 2015, STROKE, V46, P2419, DOI 10.1161/STROKEAHA.115.009136
- Silberberg J, 1997, ATHEROSCLEROSIS, V133, P105, DOI 10.1016/S0021-9150(97)00122-6
- Song IU, 2009, J NEUROL SCI, V278, P60, DOI 10.1016/j.jns.2008.11.011
- Tang CZ, 2016, MOL NEUROBIOL, V53, P2152, DOI 10.1007/s12035-015-9186-2
- van Beynum IM, 1999, CIRCULATION, V99, P2070, DOI 10.1161/01.CIR.99.16.2070
- VERHOEF P, 1994, STROKE, V25, P1924, DOI 10.1161/01.STR.25.10.1924
- Verhoef P, 1996, AM J EPIDEMIOL, V143, P845, DOI 10.1093/oxfordjournals.aje.a008828
- VONECKARDSTEIN A, 1994, ARTERIOSCLER THROMB, V14, P460, DOI 10.1161/01.ATV.14.3.460
- Wald NJ., 2008, ARCH INTERN MED, V158, P862
- Wang CY, 2014, EUR J INTERN MED, V25, P538, DOI 10.1016/j.ejim.2014.04.011
- Wang HL, 2006, NEUROL RES, V28, P25, DOI 10.1179/016164106X91834
- Warsi AA, 2004, EUR J VASC ENDOVASC, V27, P75, DOI 10.1016/j.ejvs.2003.09.001
- Weikert C, 2007, STROKE, V38, P2912, DOI 10.1161/STROKEAHA.107.486068
- Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
- Wu GH, 2017, METAB BRAIN DIS, V32, P859, DOI 10.1007/s11011-017-9978-3
- Wu XY, 2020, NUTR METAB CARDIOVAS, V30, P1861, DOI 10.1016/j.numecd.2020.07.026
- Zhang T, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019467
- Zhou F, 2022, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.727418
- Zhou ZK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01114